First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate
暂无分享,去创建一个
A. Salihoglu | N. Tuzuner | U. Ozbek | Z. Başlar | A. E. Eşkazan | T. Soysal | D. Arıca | Bulent Kantarcioglu | D. Aydın | N. Demirel | T. Elverdi | M. Ar | Y. Aydin | M. Ayer | F. Yalniz | Seniz Ongoren Aydin | A. Salihoğlu